Usage Information

Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene.
L Grunebaum, … , H De la Salle, J P Lecocq
L Grunebaum, … , H De la Salle, J P Lecocq
Published May 1, 1984
Citation Information: J Clin Invest. 1984;73(5):1491-1495. https://doi.org/10.1172/JCI111354.
View: Text | PDF
Research Article

Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene.

Abstract

The cloned complementary DNA for coagulation Factor IX (FIX) detects a frequent restriction fragment length polymorphism (RFLP) in human genomic DNAs digested with the restriction endonuclease Taq I. This genetic marker was used, in parallel with coagulation and immunological assays, to follow the segregation of an abnormal FIX gene in a large Hemophilia B family. Among the six potential female carriers, functional assays showed that four had a high probability, and two a low probability of being carriers. Analysis at the DNA level with the cDNA probe was informative in five of the six cases, and in all these five the diagnosis of carrier state was definitively confirmed. This demonstrates the feasibility of using linkage analysis at the DNA level for the genetic screening of Hemophilia B. This method has the advantages over conventional assays of giving a diagnosis of certainty, and of being applicable to early prenatal diagnosis using biopsies of trophoblast villi. At present, the single known polymorphism associated with the FIX gene restricts the application of linkage analysis to informative cases (40%), but findings of additional RFLPs in this region should improve this figure.

Authors

L Grunebaum, J P Cazenave, G Camerino, C Kloepfer, J L Mandel, P Tolstoshev, M Jaye, H De la Salle, J P Lecocq

×

Usage data is cumulative from February 2024 through February 2025.

Usage JCI PMC
Text version 123 8
PDF 50 25
Scanned page 171 6
Citation downloads 48 0
Totals 392 39
Total Views 431
(Click and drag on plot area to zoom in. Click legend items above to toggle)

Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.

Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.

Advertisement